Source: Annual Congress 2006 - Pulmonary arterial hypertension: from bench back to bedside
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. V. Volkov, E. L. Nasonov (Moscow, Russian Federation). Pulmonary arterial hypertension in scleroderma – manifestation of systemic endothelial dysfunction. Eur Respir J 2006; 28: Suppl. 50, 3162

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension and arterial stiffness in patients with systemic scleroderma Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Pulmonary hypertension in systemic scleroderma Source: Eur Respir J 2003; 22: Suppl. 45, 269s Year: 2003 Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy Source: Eur Respir J 2009; 33: 371-379 Year: 2009 Screening for pulmonary arterial hypertension in systemic sclerosis Source: Eur Respir Rev 2009; 18: 162-169 Year: 2009 Systemic consequences of pulmonary arterial hypertension Source: International Congress 2019 – State of the art session: Pulmonary vascular diseases Year: 2019 Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension Source: Eur Respir J 2010; 35: 6-8 Year: 2010 Systemic endothelial dysfunction in patients and first order relatives with pulmonary arterial hypertension Source: Annual Congress 2004 - Pulmonary hypertension Year: 2004 Pulmonary arterial hypertension in systemic sclerosis: a distinctive endotheliopathy? Source: Eur Respir J 2010; 35: 223-224 Year: 2010 Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension Source: Eur Respir J, 58 (2) 2101645; 10.1183/13993003.01645-2021 Year: 2021 Tadalafil in idiopathic or heritable pulmonary arterial hypertension compared to pulmonary arterial hypertension associated with connective tissue disease Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Pulmonary arterial manifestation of systemic inflammation in patients with COPD Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Vasodilator testing in pulmonary arterial hypertension associated with systemic sclerosis Source: Eur Respir J 2006; 28: Suppl. 50, 548s Year: 2006 Peripheral arterial stiffness and endothelial dysfunction in pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 Differences between limited and diffuse systemic sclerosis-related pulmonary arterial hypertension Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011 Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature Source: Eur Respir J 2014; 44: 1275-1288 Year: 2014 Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Assessment of platelet dysfunction in patients with pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016 Pulmonary hypertension in sickle cell disease Source: Annual Congress 2007 - ACCP1 - Pulmonary hypertension in sickle cell disease Year: 2007 Endothelial and platelet dysfunction in pulmonary hypertension due to sarcoidosis Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 The Role of Inflammation in promoting pulmonary hypertension in idiopatchi and connective tissue disease-associated PAH Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension Year: 2008